Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit
NCT ID: NCT03162341
Last Updated: 2022-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2017-08-10
2021-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Imagery as Biomarker of Gout
NCT05434858
MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs
NCT00584311
Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
NCT05546593
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560
Descriptive Analysis of Dual-energy Computed Tomography Exams of Adult Patients With Gout
NCT05065606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UltraSonography and DECT
UltraSonography and DECT will be used in patient monitoring after 6, 12 and 24 months of treatment in order to evaluate the correlation between the 2 explorations for the measurement in tophus volume change.
Those are interventions that are not part of the standard care of the patients.
ultrasonography
The tophus volume will be assess using ultrasonography.
DECT
The tophus volume will be assess using dual-energy computed tomography (DECT).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasonography
The tophus volume will be assess using ultrasonography.
DECT
The tophus volume will be assess using dual-energy computed tomography (DECT).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* uricemia ≥6 mg/dL
* warranted introduction of urate-lowering therapy according to the ACR 2012 or EULAR 2016 criteria
* signature of the informed consent
* social insurance affiliation
Exclusion Criteria
* patient under legal guardianship
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Horizon Pharma Rheumatology LLC
INDUSTRY
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tristan Pascart, MD
Role: STUDY_DIRECTOR
Hospital Group of the Catholic Institute of Lille
Sébastien Ottaviani, MD
Role: PRINCIPAL_INVESTIGATOR
Bichat Hospital of Paris
Pascal Richette, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Lariboisiere Hospital of Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Group of the Catholic Institute
Lomme, , France
Bichat Hospital
Paris, , France
Lariboisière Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P0056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.